コンテンツへスキップ
Merck
  • Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

Clinical cancer research : an official journal of the American Association for Cancer Research (2001-04-12)
L Panasci, J P Paiement, G Christodoulopoulos, A Belenkov, A Malapetsa, R Aloyz
要旨

Various mechanisms have been implicated in nitrogen mustard drug resistance. The role of these mechanisms in the development of chlorambucil drug resistance in chronic lymphocytic leukemia (CLL) is discussed. We review these mechanisms with emphasis on the emerging role of DNA repair, and specifically, recombinational repair. Inhibition of these repair processes may lead to new therapies, not only in CLL, but in other malignancies as well.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
クロランブシル
クロランブシル, European Pharmacopoeia (EP) Reference Standard
システム適合性用クロラムブシル, European Pharmacopoeia (EP) Reference Standard